Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)
- PMID: 32769659
- DOI: 10.1097/AOG.0000000000004103
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)
Abstract
Recent evidence supports the use of an early, short course of glucocorticoids in patients with COVID-19 who require mechanical ventilation or oxygen support. As the number of coronavirus disease 2019 (COVID-19) cases continues to increase, the number of pregnant women with the disease is very likely to increase as well. Because pregnant women are at increased risk for hospitalization, intensive care unit admission, and mechanical ventilation support, obstetricians will be facing the dilemma of initiating maternal corticosteroid therapy while weighing its potential adverse effects on the fetus (or neonate if the patient is postpartum and breastfeeding). Our objective is to summarize the current evidence supporting steroid therapy in the management of patients with acute respiratory distress syndrome and COVID-19 and to elaborate on key modifications for the pregnant patient.
Comment in
-
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).Obstet Gynecol. 2021 Feb 1;137(2):378-379. doi: 10.1097/AOG.0000000000004272. Obstet Gynecol. 2021. PMID: 33481518 No abstract available.
-
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).Obstet Gynecol. 2021 Feb 1;137(2):379-380. doi: 10.1097/AOG.0000000000004271. Obstet Gynecol. 2021. PMID: 33481519 No abstract available.
-
In Reply.Obstet Gynecol. 2021 Feb 1;137(2):380-381. doi: 10.1097/AOG.0000000000004273. Obstet Gynecol. 2021. PMID: 33481520 No abstract available.
References
-
- World Health Organization. Coronavirus disease (COVID-2019) situation reports. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio.... Retrieved July 2, 2020.
-
- Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ 2020;369:m2107.
-
- Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–June 7, 2020. MMWR Morb Mortal Wkly Rep 2020;69:769–75.
-
- Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med 2017;377:562–72.
-
- Karakike E, Giamarellos-Bourboulis EJ. Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis. Front Immunol 2019;10:55.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials